Renal Cancer Research Review, Issue 1

In this issue:

Retroperitoneal lymphadenectomy for high risk, nonmetastatic RCC
Survival outcomes for patients with localised upper tract urothelial carcinoma
Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma
Cabozantinib in the treatment of advanced RCC following VEGR-targeted therapy
Adjuvant sunitinib for high-risk RCC after nephrectomy: Subgroup analyses
Safety and efficacy of nivolumab + ipilimumab in mRCC
Mannitol vs placebo during partial nephrectomy
Avelumab in metastatic urothelial carcinoma after platinum failure

Please login below to download this issue (PDF)

Subscribe